Hironori Hara1, MD; Neil O'Leary2, PhD; Masafumi Ono1, MD; Yoshinobu Onuma1, MD, PhD; Patrick W. Serruys1, MD, PhD
1. Department of Cardiology, National University of Ireland, Galway (NUIG), Galway, Ireland; 2. Health Research Board Clinical Research Facility, Department of Medicine, NUIG, Galway, Ireland
Introduction
In the current guidelines for acute coronary syndrome (ACS), the GRACE risk score is recommended for risk stratification. The GRACE risk score 2.0 provides the risk of death and myocardial infarction (MI) after ACS, but it does not provide a bleeding risk prediction. The PRECISE-DAPT and PARIS scores were developed from patient populations treated with percutaneous coronary intervention (PCI) regardless of their clinical presentations. They predict out-of-hospital bleeding risk. The PARIS score also provides a thrombotic risk prediction. As a tool for mortality prediction, the logistic clinical SYNTAX score was redeveloped from the GLOBAL LEADERS trial12. Recently, the PRAISE score, ...